Broader health insurance and PBM sector stocks including Centene, CVS, Elevance Health and Humana decline as investors react ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

UnitedHealth's high medical costs and lower-than-expected revenue in the fourth quarter underscored persistent challenges at ...

UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...

Garth Reynolds, executive director of the Illinois Pharmacists Association, writes about what he calls a crisis related to ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...